When Complex Products Meet Complex Regulation - Who Helps You Stay Ahead
Combination Products and Medical Devices (CPMD) Consulting Ltd. joins Bionow to support pharma and medtech SMEs with decisive regulatory and technical leadership.
As small and medium-sized pharma and medical technology companies accelerate the development of drug–device combination products, many encounter the same critical challenges: increasing regulatory scrutiny, fragmented documentation, unclear lifecycle strategies, and the need to align technical, quality, and commercial decisions at pace.
CPMD Consulting Ltd. has joined the Bionow network to help organisations overcome these barriers with a commercially focused, results-driven approach grounded in deep industry experience.
CPMD is a specialist consultancy providing end-to-end regulatory, technical, and lifecycle support for combination products and medical devices. With expertise spanning FDA, EMA, EU MDR, and Notified Body expectations, CPMD helps teams bring clarity, structure, and forward planning. This enables faster market entry and supports long-term product success. At the core of CPMD’s approach is an unwavering commitment to quality, patient safety, and integrity in every engagement – ensuring that every solution is both compliant and commercially robust.
CPMD supports pharma and medtech SMEs through:
• Strategic regulatory pathway definition to enable efficient approvals and market access
• Design control and documentation expertise to meet and exceed compliance requirements
• QMS development, harmonisation, and remediation to improve operational performance
• Technical and quality leadership across development and lifecycle management
• Market readiness, risk mitigation, and post-market strategy to protect product value
• Executive and cross-functional training to build internal capability and agility
By integrating regulatory, technical, and commercial insight, CPMD enables companies to move faster, reduce risk, and maximise the value of their products—particularly during periods of rapid growth or market expansion.
A CPMD spokesperson said: “Joining Bionow strengthens our ability to support SMEs developing increasingly complex products in a demanding regulatory environment. We bring commercial focus, structured clarity, and disciplined execution—helping companies accelerate progress while maintaining compliance and consistently delivering safe, effective technologies to patients.”
CPMD looks forward to collaborating with fellow Bionow members and contributing to the growth of the region’s combination product and medical device ecosystem.
Bionow members seeking to accelerate development, resolve regulatory challenges, or strengthen their technical and quality foundations are encouraged to get in touch with CPMD to discuss how we can support your programmes and deliver measurable results. Find out more: www.cpmd.co.uk